Jacobson Allan Steven bought PTCT
October 3, 2025 · Form 4 insider transaction
Jacobson Allan Steven bought 12,000 shares of PTC Therapeutics, Inc. at $30.86 per share, a transaction worth $370.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,000
Price
$30.86
Total value
$370.3K
InsiderJacobson Allan Steven
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 3, 2025
Filing dateOctober 7, 2025
Shares owned after29,451
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 12, 2025.